ITSA-1 50 mg | 99.82%
TargetMol
ITSA-1 is membrane permeable and specifically suppresses TSA inhibition of HDAC (histone deacetylase), but shows no activity towards other HDAC inhibitors.
More Information Supplier PageITSA-1
Search Results
Jervine 10 mg | 99.57%
TargetMol
The biological activity of Jervine is mediated via its interaction with the 7 passes transmembrane protein Smoothened. Jervine binds with and inhibits smoothened, which is an integral part of the Hedgehog signaling pathways. With smoothened inhibited, the GLI1 transcription cannot be activated and Hedgehog target genes cannot be transcribed.
More Information Supplier PageJervine
Jervine 5 mg | 99.57%
TargetMol
The biological activity of Jervine is mediated via its interaction with the 7 passes transmembrane protein Smoothened. Jervine binds with and inhibits smoothened, which is an integral part of the Hedgehog signaling pathways. With smoothened inhibited, the GLI1 transcription cannot be activated and Hedgehog target genes cannot be transcribed.
More Information Supplier PageJervine
Rebaudioside C 50 mg | 99.85%
TargetMol
Dulcoside B (Rebaudioside C) is a natural sweeteners used for diabetics and others on carbohydrate-controlled diets.
More Information Supplier PageRebaudioside C
Antitumor agent-21 10 mg | Purity Not Available
TargetMol
Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
More Information Supplier PageAntitumor agent-21
Antitumor agent-21 25 mg | Purity Not Available
TargetMol
Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
More Information Supplier PageAntitumor agent-21
Antitumor agent-21 50 mg | Purity Not Available
TargetMol
Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
More Information Supplier PageAntitumor agent-21
Antitumor agent-21 5 mg | Purity Not Available
TargetMol
Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
More Information Supplier PageAntitumor agent-21
Liquiritigenin 50 mg | 99.70%
TargetMol
Liquiritigenin, a flavonoid aglycone from licorice, is a highly selective estrogen receptor β (ERβ) agonist.
More Information Supplier PageLiquiritigenin
Dizocilpine Maleate 50 mg | 99.96%
TargetMol
Dizocilpine Maleate (MK 801) is a potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) with Kd of 37.2 nM in rat brain membranes. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role.
More Information Supplier PageDizocilpine Maleate
